12 drug companies added to 46-state suit against price gouging — 6 insights

Attorney generals from 46 states are suing an additional 12 pharmaceutical companies, alleging they are illegally raising generic drug prices, CNBC reports.

Here's what you should know:

1. The attorney generals filed their initial suit in 2016 against several large pharmaceutical companies including Mylan and Teva Pharmaceuticals.

2. The attorney generals are requesting their suit be amended to include at least a dozen new companies.

3. The 12 possible new defendants are: Actavis Holdco; Actavis Pharma; Ascend Laboratories; Apotex Corp.; Dr. Reddy's Laboratories; Emcure Pharmaceuticals; Glenmark Pharmaceuticals; Lannett Company; Par Pharmaceutical Companies; Sandoz; Sun Pharmaceuticals and Zydus Pharmaceuticals.

4. CNBC reports the companies colluded to raise prices.

5. The states are seeking injunctive relief, civil penalties and disgorgement of profits.

6. Connecticut Attorney General George Jepsen is leading the state coalition.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast